<code id='7CC7BE761D'></code><style id='7CC7BE761D'></style>
    • <acronym id='7CC7BE761D'></acronym>
      <center id='7CC7BE761D'><center id='7CC7BE761D'><tfoot id='7CC7BE761D'></tfoot></center><abbr id='7CC7BE761D'><dir id='7CC7BE761D'><tfoot id='7CC7BE761D'></tfoot><noframes id='7CC7BE761D'>

    • <optgroup id='7CC7BE761D'><strike id='7CC7BE761D'><sup id='7CC7BE761D'></sup></strike><code id='7CC7BE761D'></code></optgroup>
        1. <b id='7CC7BE761D'><label id='7CC7BE761D'><select id='7CC7BE761D'><dt id='7CC7BE761D'><span id='7CC7BE761D'></span></dt></select></label></b><u id='7CC7BE761D'></u>
          <i id='7CC7BE761D'><strike id='7CC7BE761D'><tt id='7CC7BE761D'><pre id='7CC7BE761D'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:5
          James Fanale, the former CEO and president of Care New England, and his wife Deb (left) on their front porch. -- health coverage from STAT
          Courtesy Ryan Pickering

          PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road Race — walking up the hills, running down them — for seven miles. Fellow runners encouraged him to “keep trying” whenever he slowed down. But they couldn’t have known — along with most of the people in Fanale’s professional orbit — that he was battling Stage 4 lung cancer.

          “Many times, I wanted to say ‘Listen buddy, you don’t know what I’ve got in me,’” Fanale recalled recently with a chuckle.

          advertisement

          In December 2022, on the day Fanale retired as president and CEO of Care New England, he shared his diagnosis with a Globe reporter but requested it be kept private. He was handing the reins to new CEO Dr. Michael Wagner after six years leading the second largest health care system in Rhode Island.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Beam Therapeutics to lay off 20% of its staff, re
          Beam Therapeutics to lay off 20% of its staff, re

          BeamTherapeuticsco-founderDavidLiuCourtesyStephanieMitchell/HarvardBeamTherapeuticssaidThursdaymorni

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          CEOs share strategies for surviving biotech slump

          JonathanWosenforSTATCARLSBAD,Calif.—BiotechCEOsleadingcellandgenetherapycompaniesspokefranklyataconf